FERME LA PORCTEE INCBusiness Directories,Company Directories

Company Name: Corporate Name:	FERME LA PORC-TEE INC
Company Title:
Company Description:
Keywords to Search:
Company Address:	139 309 Rte N,LAC-DES-ILES,QC,Canada
ZIP Code: Postal Code:	J0W1J0
Telephone Number:	8195972286
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	075102
USA SIC Description:	Livestock Breeders
Number of Employees:	1 to 4
Sales Amount:	Less than $500,000
Credit History: Credit Report:	Very Good
Contact Person:	Alfred Grogg
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
LA MAISON DU PATRIOTE
GARAGE JEAN-YVES PICHE TRANS
FERME LA PORC-TEE INC

Next company profile:
DOMAINE VALIQUETTE PROVOST ENR
DOMAINE DES PRES
DOMAINE DES PRES

Company News:

Extracellular LGALS3BP regulates neural progenitor position . . . - Nature
Here, we study the role of LGALS3BP, so far known as a cancer biomarker, which is a secreted protein enriched in human neural progenitors (NPCs) We show that individuals with LGALS3BP de novo
LGALS3BP galectin 3 binding protein [ (human)]
LGALS3BP has been found elevated in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV) It appears to be implicated in immune response associated with natural killer (NK) and lymphokine-activated killer (LAK) cell cytotoxicity
Extracellular LGALS3BP: a potential disease marker and actionable . . .
In this work, we demonstrated that vesicular galectin‐3‐binding protein (LGALS3BP), a glycosylated protein overexpressed in a variety of human malignancies, is a potential GBM disease marker and can be efficiently targeted by a specific antibody–drug conjugate (ADC)
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating . . .
LGALS3BP, also referred as Gal-3BP, Mac2-BP, or 90 K, is a heavily glycosylated, secreted protein prominently localized at the surface of cancer-derived extracellular vesicles (EVs)
Lectin Galactoside-binding Soluble 3 Binding Protein (LGALS3BP) Is a . . .
Here we used affinity chromatography of tumor cell extracts to identify LGALS3BP as a novel sialic acid-dependent ligand for human Siglec-9 and for other immunomodulatory Siglecs, such as Siglec-5 and Siglec-10 In contrast, the mouse homolog Siglec-E binds to murine LGALS3BP with lower affinity
Role of galectin 3 binding protein in cancer progression: a potential . . .
The lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a secreted, hyperglycosylated protein expressed by the majority of human cells It was first identified as cancer and metastasis associated protein, while its role in innate
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating . . .
Our findings establish that circulating LGALS3BP is a potential biomarker for liquid biopsy and uncover this protein as a suitable target for therapeutic strategies combining 1959-sss DM4 ADC with an anti-PD-1 ICI for the treatment of LGALS3BP expressing neuroblastoma